For the year ending 2025-12-31, TMDX made $605,494K in revenue. $190,291K in net income. Net profit margin of 31.43%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 605,494 | 441,540 | ||
| Product | 77,822 | - | ||
| Service | 164,866 | - | ||
| Total cost of revenue | 242,688 | 179,459 | ||
| Gross profit | 362,806 | 262,081 | ||
| Research, development and clinical trials | 69,055 | 55,968 | ||
| Selling, general and administrative | 185,168 | 168,617 | ||
| Total operating expenses | 254,223 | 224,585 | ||
| Income (loss) from operations | 108,583 | 37,496 | ||
| Interest expense | 13,782 | 14,409 | ||
| Interest income and other income (expense), net | 12,721 | 12,693 | ||
| Total other income (expense), net | -1,061 | -1,716 | ||
| Income (loss) before income taxes | 107,522 | 35,780 | ||
| (provision) benefit for income taxes | -82,769 | 316 | ||
| Net income (loss) | 190,291 | 35,464 | ||
| Basic EPS | 5.6 | 1.07 | ||
| Diluted EPS | 4.87 | 1.01 | ||
| Basic Average Shares | 33,993,468 | 33,229,953 | ||
| Diluted Average Shares | 40,540,694 | 35,216,837 | ||
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX)